Research and experimental development on natural sciences and engineering
BIOMOLEX AS
Revenue 2024
NOK 301,000
Operating profit
NOK −401,000
Equity
NOK −245,000
Incorporated
2001
Share capital
NOK 832,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 301k | |
| Total operating costs | 703k | |
| Operating profit (EBIT) | −401k | |
| Net financial items | −73 | |
| Profit for the year | −402k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 961 | |
| of which current assets | 961 | |
| Equity | −245k | |
| Total liabilities | 246k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.